CV004-007 Thrombosis Chamber Study

PHASE1CompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

March 31, 2016

Study Completion Date

March 31, 2016

Conditions
Thrombosis
Interventions
DRUG

BMS-986120

DRUG

Aspirin

DRUG

Clopidogrel

Trial Locations (1)

EH16 4SA

Local Institution, Edinburgh

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY